Spinal extradural metastasis: Review of current treatment options

CA Cancer Journal for Clinicians

Volumn 58, Issue 4, 2008, Pages 245-259

  Bartels, Ronald H M A ^a,b   Van Der Linden, Yvette M ^c   Van Der Graaf, Winette T A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c Radiotherapeutic Institute Friesland   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; CORTICOSTEROID; DEXAMETHASONE; PAMIDRONIC ACID; RADIOISOTOPE; RHENIUM 186; STRONTIUM 89; ZOLEDRONIC ACID;

ALGORITHM; BONE MARROW DEPRESSION; BONE METASTASIS; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PAIN; CLINICAL FEATURE; CLINICAL TRIAL; DIGESTIVE SYSTEM PERFORATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; INTENSITY MODULATED RADIATION THERAPY; KYPHOPLASTY; LEUKOPENIA; LIFE EXPECTANCY; LOW DRUG DOSE; MEDICAL CARE; NEUROLOGIC DISEASE; PERCUTANEOUS VERTEBROPLASTY; PNEUMONIA; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; SPINE METASTASIS; THROMBOCYTOPENIA; TUMOR BIOPSY; WOUND INFECTION;

ALGORITHMS; BIOPSY; HUMANS; RADIOSURGERY; RADIOTHERAPY, INTENSITY-MODULATED; SPINAL NEOPLASMS; SURVIVAL RATE; VERTEBROPLASTY;

EID: 48149103405     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/CA.2007.0016     Document Type: Review

References (115)

1. Perrin RG, Laxton AW. Metastatic spine disease: epidemiology, pathophysiology, and evaluation of patients. Neurosurg Clin N Am 2004;15:365-373.
2. Jacobs WB, Perrin RG. Evaluation and treatment of spinal metastases: an overview. Neurosurg Focus 2001;11:e10.
3. Witham TF, Khavkin YA, Gallia GL, et al. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol 2006;2:87-94.
4. Manabe J, Kawaguchi N, Matsumoto S, Tanizawa T. Surgical treatment of bone metastasis: indications and outcomes. Int J Clin Oncol 2005;10:103-111.
5. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
6. Loblaw DA, Perry J, Chambers A, Laperriere NJ. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol 2005;23:2028-2037.
7. Agarawal JP, Swangsilpa T, van der Linden Y, et al. The role of external beam radiotherapy in the management of bone metastases. Clin Oncol (R Coll Radiol) 2006;18:747-760.
8. Lewandrowski KU, Bell GR, McLain RF. Cancer of the spine: how big is the problem?, in McLain RF. Cancer in the Spine: Comprehensive Care. Totowa, NJ: Humana Press; 2006:1-5.
9. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12:6243s-6249s.
10. Perrin RG. Metastatic tumors of the axial spine. Curr Opin Oncol 1992;4:525-532.
11. Simmons ED, Zheng Y. Vertebral tumors: surgical versus nonsurgical treatment. Clin Orthop Relat Res 2006;443:233-247.
12. Moore KR. Radiology of metastatic spine cancer. Neurosurg Clin N Am 2004;15:381-390.
13. Schiff D, O'Neill BP, Suman VJ. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology 1997;49:452-456.
14. Bilsky MH. New therapeutics in spine metastases. Expert Rev Neurother 2005;5:831-840.
15. van der Linden YM, Dijkstra SP, Vonk EJ, et al. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 2005;103:320-328.
16. Hamaoka T, Madewell JE, Podoloff DA, et al. Bone imaging in metastatic breast cancer. J Clin Oncol 2004;22:2942-2953.
17. Kienstra GE, Terwee CB, Dekker FW, et al. Prediction of spinal epidural metastases. Arch Neurol 2000;57:690-695.
18. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-138.
19. Frankel HL, Hancock DO, Hyslop G, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia 1969;7:179-192.
20. Frazier CH. Surgery of the Spine and Spinal Cord. New York, NY: Appleton and Co.; 1918.
21. Bérard L. Les tumeurs du rachis. Second Internat Congress of Surgery 1908;2:735-784.
22. Tietze A. Chirurgische Eingriffe bei metastatischem Carcinom der Wirbelsäule. Beitr z klin Chir 1911;73:785-814.
23. Leddy ET. The roentgen treatment of metastasis to the vertebrae and the bones of the pelvis from carcinoma of the breast. Am J Roentgenol 1930;24:657-672.
24. Thwaites DI, Tuohy JB. Back to the future: the history and development of the clinical linear accelerator. Phys Med Biol 2006;51:R343-R362.
25. Ginzton EL, Nunan CS. History of microwave electron linear accelerators for radiotherapy. Int J Radiat Oncol Biol Phys 1985;11: 205-216.
26. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 1978;3:40-51.
27. Kleinman WB, Kiernan HA, Michelsen WJ. Metastatic cancer of the spinal column. Clin Orthop Relat Res 1978;136:166-172.
28. Black P. Spinal metastasis: current status and recommended guidelines for management. Neurosurgery 1979;5:726-746.
29. Young RF, Post EM, King GA. Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg 1980;53:741-748.
30. Ashizawa R, Ohtsuka K, Kamimura M, et al. Percutaneous transpedicular biopsy of thoracic and lumbar vertebrae - method and diagnostic validity. Surg Neurol 1999;52:545-551.
31. Brenac F, Huet H. Diagnostic accuracy of the percutaneous spinal biopsy. Optimization of the technique [in French]. Neuroradiology 2001;28:7-16.
32. Park P, Lamarca F, McLain RF. Biopsy. Principles and approaches, in McLain RF. Cancer in the Spine: Comprehensive Care. Totowa, NJ: Humana Press; 2006:227-231.
33. Rades D, Bremer M, Goehde S, et al. Spondylodiscitis in patients with spinal cord compression: a possible pitfall in radiation oncology. Radiother Oncol 2001;59:307-309.
34. van der Linden YM, Steenland E, van Houwelingen HC, et al. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study. Radiother Oncol 2006;78:245-253.
35. Heary RF, Bono CM. Metastatic spinal tumors. Neurosurg Focus 2001;11:e1.
36. Sciubba DM, Gokaslan ZL, Suk I, et al. Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease. Eur Spine J 2007;16:1659-1667.
37. Shehadi JA, Sciubba DM, Suk I, et al. Surgical treatment strategies and outcome in patients with breast cancer metastatic to the spine: a review of 87 patients. Eur Spine J 2007;16:1179-1192.
38. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366:643-648.
39. Patchell RA. Surgery helps relieve spinal cord compression caused by metastatic cancer. Available at: www.cancer.gov/clinicaltrials/results/ spinalcord-compression0603. Accessed December 10, 2007.
40. Lutz ST, Chow EL, Hartsell WF, Konski AA. A review of hypofractionated palliative radiotherapy. Cancer 2007;109:1462-1470.
41. Samant R, Gooi AC. Radiotherapy basics for family physicians. Potent tool for symptom relief. Can Fam Physician 2005;51:1496-1501.
42. Chow E, Davis L, Panzarella T, et al. Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys 2005;61:870-873.
43. Chow E, Harth T, Hruby G, et al. How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol (R Coll Radiol) 2001;13:209-218.
44. Hosono N, Ueda T, Tamura D, et al. Prognostic relevance of clinical symptoms in patients with spinal metastases. Clin Orthop Relat Res 2005;436:196-201.
45. Tokuhashi Y, Matsuzaki H, Toriyama S, et al. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine 1990;15:1110-1113.
46. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine 2001;26:298-306.
47. van der Linden YM, Dijkstra SP, Vonk EJ, et al. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 2005;103:320-328.
48. Bartels RH, Feuth T, van der Maazen R, et al. Development of a model with which to predict the life expectancy of patients with spinal epidural metastasis. Cancer 2007;110:2042-2049.
49. Chow E, Harris K, Fung K. Successful validation of a survival prediction model in patients with metastases in the spinal column. Int J Radiat Oncol Biol Phys 2006;65:1522-1527.
50. Tokuhashi Y, Matsuzaki H, Oda H, et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 2005;30:2186-2191.
51. Peters LJ. The ESTRO Regaud lecture. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response. Radiother Oncol 1990;17:177-190.
52. Chow E, Harris K, Fan G, et al. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 2007;25:1423-1436.
53. Sze WM, Shelley M, Held I, Mason M. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy. Cochrane Database of Systematic Reviews [database online] 2004; 2:CD004721. Available at: http://www.cochrane.org/reviews/en/ab004721.html. Accessed December 10, 2007.
54. Wu JS, Wong R, Johnston M, et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003;55:594-605.
55. Koswig S, Budach V. Remineralization and pain relief in bone metastases after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study [in German]. Strahlenther Onkol 1999;175:500-508.
56. van der Linden YM, Kroon HM, Dijkstra SP, et al. Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomised trial. Radiother Oncol 2003;69:21-31.
57. van der Linden YM, Lok JJ, Steenland E, et al. Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys 2004;59:528-537.
58. Chow E, Hoskin PJ, Wu J, et al. A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. Clin Oncol (R Coll Radiol) 2006;18:125-128.
59. A Phase III International Randomized Trial of Single Versus Multiple Fractions for Re-Irradiation of Painful Bone Metastases. National Cancer Institute of Canada. Available at: http:// www.ctg.queensu.ca/public/ Clinical_Trials/public_ph_3_trial_summary.html#SC20. Accessed December 10, 2007.
60. Roos DE, Turner SL, O'Brien PC, et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005;75:54-63.
61. Maranzano E, Bellavita R, Rossi R, et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol 2005;23:3358-3365.
62. Rades D, Fehlauer F, Stalpers LJ, et al. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study. Cancer 2004;101:2687-2692.
63. Rades D, Stalpers LJ, Veninga T, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005;23:3366-3375.
64. Rades D, Stalpers LJ, Veninga T, Hoskin PJ. Spinal reirradiation after short-course RT for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2005;63:872-875.
65. Hoskin PJ, Grover A, Bhana R. Metastatic spinal cord compression: radiotherapy outcome and dose fractionation. Radiother Oncol 2003;68:175-180.
66. Helweg-Larsen S, Sørensen PS, Kreiner S. Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 2000;46:1163-1169.
67. Chang EL, Shiu AS, Mendel E, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 2007;7:151-160.
68. Gibbs IC, Kamnerdsupaphon P, Ryu MR, et al. Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol 2007;82:185-190.
69. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine 2007;32:193-199.
70. Jin JY, Chen Q, Jin R, et al. Technical and clinical experience with spine radiosurgery: a new technology for management of localized spine metastases. Technol Cancer Res Treat 2007;6:127-133.
71. Ryu S, Fang Y, Rock J, et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer 2003;97:2013-2018.
72. Nieder C, Grosu AL, Andratschke NH, Molls M. Update of human spinal cord reirradiation tolerance based on additional data from 38 patients. Int J Radiat Oncol Biol Phys 2006;66:1446-1449.
73. Ryu S, Jin JY, Jin R, et al. Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery. Cancer 2007;109:628-636.
74. Roqué M, Martinez-Zapata MJ, Alonso-Coello P, et al. Radioisotopes for metastatic bone pain. Cochrane Database of Systematic Reviews [database online] 2003;4:CD003347. Available at: http://www.cochrane.org/reviews/en/ ab003347.html. Accessed December 10, 2007.
75. Bauman G, Charette M, Reid R, Sathya J. Radiopharmaceuticals for the palliation of painful bone metastasis - a systemic review. Radiother Oncol 2005;75:258-270.
76. Finlay IG, Mason MD, Shelly M. Radioisotopes for the palliation of metastatic bone cancer: a systematic review. Lancet Oncol 2005;6:392-400.
77. Siegal T, Tiqva P, Siegal T. Vertebral body resection for epidural compression by malignant tumors. Results of forty-seven consecutive operative procedure s . J Bone Joint Surg Am 1985;67:375-382.
78. Sundaresan N, Galicich JH, Bains MS, et al. Vertebral body resection in the treatment of cancer involving the spine. Cancer 1984;53:1393-1396.
79. Sundaresan N, Galicich JH, Lane JM, et al. Treatment of neoplastic epidural cord compression by vertebral body resection and stabilization. J Neurosurg 1985;63:676-684.
80. Huang TJ, Hsu RW, Li YY, Cheng CC. Minimal access spinal surgery (MASS) in treating thoracic spine metastasis. Spine 2006;31:1860-1863.
81. Hirabayashi H, Ebara S, Kinoshita T, et al. Clinical outcome and survival after palliative surgery for spinal metastases: palliative surgery in spinal metastases. Cancer 2003;97:476-484.
82. Holman PJ, Suki D, McCutcheon I, et al. Surgical management of metastatic disease of the lumbar spine: experience with 139 patients. J Neurosurg Spine 2005;2:550-563.
83. Villavicencio AT, Oskouian RJ, Roberson C, et al. Thoracolumbar vertebral reconstruction after surgery for metastatic spinal tumors: long-term outcomes. Neurosurg Focus 2005;19:E8.
84. North RB, LaRocca VR, Schwartz J, et al. Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience. J Neurosurg Spine 2005;2:564-573.
85. Klimo P Jr, Thompson CJ, Kestle JR, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro Oncol 2005;7:64-76.
86. Thomas KC, Nosyk B, Fisher CG, et al. Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. Int J Radiat Oncol Biol Phys 2006;66:1212-1218.
87. Patil CG, Lad SP, Santarelli J, Boakye M. National implant complications and outcomes after surgery for spinal metastasis from 1993-2002. Cancer 2007;110:625-630.
88. Ghogawala Z, Mansfield FL, Borges LF. Spinal radiation before surgical decompression adversely affects outcomes of surgery for symptomatic metastatic spinal cord compression. Spine 2001;26:818-824.
89. Pilitsis JG, Rengachary SS. The role of vertebroplasty in metastatic spinal disease. Neurosurg Focus 2001;11:e1.
90. Bròdano GB, Cappuccio M, Gasbarrini A, et al. Vertebroplasty in the treatment of vertebral metastases: clinical cases and review of the literature. Eur Rev Med Pharmacol Sci 2007;11:91-100.
91. Wenger M. Vertebroplasty for metastasis. Med Oncol 2003;20:203-209.
92. Jang JS, Lee SH. Efficacy of percutaneous vertebroplasty combined with radiotherapy in osteolytic metastatic spinal tumors. J Neurosurg Spine 2005;2:243-248.
93. Gerszten PC, Germanwala A, Burton SA, et al. Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures. Neurosurg Focus 2005;18:e1.
94. Deramond H, Depriester C, Toussaint P. Vertebroplasty and percutaneous interventional radiology in bone metastases: techniques, indications, contra-indications [in French]. Bull Cancer Radiother 1996;83:277-282.
95. Cotten A, Dewatre F, Cortet B, et al. Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology 1996;200:525-530.
96. Fourney DR, Schomer DF, Nader R, et al. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg 2003;98:21-30.
97. De Negri P, Tirri T, Paternoster G, Modano P. Treatment of painful osteoporotic or traumatic vertebral compression fractures by percutaneous vertebral augmentation procedures: a nonrandomized comparison between vertebroplasty and kyphoplasty. Clin J Pain 2007;23:425-430.
98. Tschirhart CE, Finkelstein JA, Whyne CM. Optimization of tumor volume reduction and cement augmentation in percutaneous vertebroplasty for prophylactic treatment of spinal metastases. J Spinal Disord Tech 2006;19:584-590.
99. Fuentes S, Métellus P, Pech-Gourg G, et al. Open kyphoplasty for management of metastatic and severe osteoporotic spinal fracture. Technical note. J Neurosurg Spine 2007;6:284-288.
100. Fuentes S, Métellus P, Pech-Gourg G, et al. Traitement par kypkoplastie à foyer ouvert des métastases rachidiennes. Neurochirurgie 2007;53:49-53.
101. Klein SL, Sanford RA, Muhlbauer MS. Pediatric spinal epidural metastases. J Neurosurg 1991;74:70-75.
102. Raffel C, Neave VC, Lavine S, McComb JG. Treatment of spinal cord compression by epidural malignancy in childhood. Neurosurgery 1991;28:349-352.
103. Higgins SA, Peschel RE. Hodgkin's disease with spinal cord compression. A case report and a review of the literature. Cancer 1995;75:94-98.
104. McDonald AC, Nicoll JA, Rampling RP. Non-Hodgkin's lymphoma presenting with spinal cord compression; a clinicopathological review of 25 cases. Eur J Cancer 2000;36:207-213.
105. Hendriksen PJ, Dits NF, Kokame K, et al. Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Res 2006;66:5012-5020.
106. Lower EE, Glass EL, Bradley DA, et al. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Breast Cancer Res Treat 2005;90:65-70.
107. Klimo P Jr, Kestle JR, Schmidt MH. Clinical trials and evidence-based medicine for metastatic spine disease. Neurosurg Clin N Am 2004;15:549-564.
108. Vecht CJ, Haaxma-Reiche H, van Putten WL, et al. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 1989;39:1255-1257.
109. Heimdal K, Hirschberg H, Slettebø H, et al. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol 1992;12:141-144.
110. Sørensen S, Helweg-Larsen S, Mouridsen H, Hansen HH. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer 1994;30A: 22-27.
111. Verì A, D'Andrea MR, Bonginelli P, Gasparini G. Clinical usefulness of bisphosphonates in oncology: treatment of bone metastases, antitumoral activity and effect on bone resorption markers. Int J Biol Markers 2007;22:24-33.
112. Heidenreich A, Hofmann R, Engelmann UH. The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer. J Urol 2001;165:136-140.
113. Lipton A, Theriault RL, Hortobagyi GN, et al. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer 2000;88:1082-1090.
114. Yuen KK, Shelley M, Sze WM, et al. Bisphosphonates for advanced prostate cancer. Cochrane Database of Systematic Reviews [database online] 2006;4:CD006250. Available at: http://www.cochrane.org/reviews/en/ab006250.html. Accessed December 10, 2007.
115. Carteni G, Bordonaro R, Giotta F, et al. Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial. Oncologist 2006;11:841-848.